ABCL
Price
$3.99
Change
-$0.06 (-1.48%)
Updated
Sep 3 closing price
Capitalization
1.19B
68 days until earnings call
UNBX
Price
$0.06
Change
-$0.01 (-14.29%)
Updated
Sep 3 closing price
Capitalization
1.1M
Interact to see
Advertisement

ABCL vs UNBX

Header iconABCL vs UNBX Comparison
Open Charts ABCL vs UNBXBanner chart's image
AbCellera Biologics
Price$3.99
Change-$0.06 (-1.48%)
Volume$4.24M
Capitalization1.19B
Unity Biotechnology
Price$0.06
Change-$0.01 (-14.29%)
Volume$34.64K
Capitalization1.1M
ABCL vs UNBX Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. UNBX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and UNBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ABCL: $3.99 vs. UNBX: $0.06)
Brand notoriety: ABCL and UNBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 78% vs. UNBX: 5%
Market capitalization -- ABCL: $1.19B vs. UNBX: $1.1M
ABCL [@Biotechnology] is valued at $1.19B. UNBX’s [@Biotechnology] market capitalization is $1.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileUNBX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • UNBX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than UNBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while UNBX’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 5 bearish.
  • UNBX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, UNBX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -8.28% price change this week, while UNBX (@Biotechnology) price change was -20.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.19B) has a higher market cap than UNBX($1.1M). ABCL YTD gains are higher at: 36.177 vs. UNBX (-92.749).
ABCLUNBXABCL / UNBX
Capitalization1.19B1.1M107,804%
EBITDA-197.92MN/A-
Gain YTD36.177-92.749-39%
P/E RatioN/AN/A-
Revenue32.9MN/A-
Total Cash553MN/A-
Total Debt142MN/A-
FUNDAMENTALS RATINGS
UNBX: Fundamental Ratings
UNBX
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLUNBX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 6 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 6 days ago
65%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WMG33.11-0.24
-0.72%
Warner Music Group Corp
LIDR2.79-0.03
-1.06%
AEye
GLAD26.14-0.28
-1.06%
Gladstone Capital Corp
FRPT54.68-1.14
-2.04%
Freshpet
YHC0.81-0.06
-6.69%
LQR House Inc

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-1.48%
CRSP - ABCL
58%
Loosely correlated
+0.61%
RXRX - ABCL
58%
Loosely correlated
-0.64%
ABSI - ABCL
54%
Loosely correlated
+1.71%
NTLA - ABCL
52%
Loosely correlated
+2.72%
BEAM - ABCL
51%
Loosely correlated
+15.02%
More

UNBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNBX has been loosely correlated with INMB. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if UNBX jumps, then INMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNBX
1D Price
Change %
UNBX100%
-2.34%
INMB - UNBX
54%
Loosely correlated
-2.96%
OGEN - UNBX
36%
Loosely correlated
+1.94%
HOFBF - UNBX
34%
Loosely correlated
N/A
ABCL - UNBX
30%
Poorly correlated
-3.11%
CLLS - UNBX
29%
Poorly correlated
+0.66%
More